Med tech company BioTelemetry pops 12% after it says it will aid in the Apple-Stanford heart study

A customer tries out an Apple Watch Nike+ at an Apple Store in the SoHo neighborhood of Manhattan, October 28, 2016 in New York City.

Drew Angerer | Getty Images

A customer tries out an Apple Watch Nike+ at an Apple Store in the SoHo neighborhood of Manhattan, October 28, 2016 in New York City.

Shares of BioTelemetry rose about 12 percent on Thursday morning, after the medical technology company announced it will participate in a joint study conducted by Apple and Stanford University.

BioTelemetry, a medical technology company, said it will help with Apple and Stanford’s newly announced heart study, which focuses on detecting irregular heart rhythms using the Apple Watch and a dedicated app.

BioTelemetry, which is just shy of a $1 billion market capitalization, saw…

Read Story